Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JCO.20.00390 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Letter to the Editor by Lohmann and Fernandes.
J Pediatr Surg
August 2024
Department of Pediatric Surgery, Osaka Women's and Children's Hospital, Izumi, Japan.
Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. Reply.
N Engl J Med
July 2023
RIKEN, Yokohama, Japan
Factors reducing psychological satisfaction after the Nuss procedure in pediatric patients.
Asian J Endosc Surg
January 2023
Department of Pediatric Surgery, Graduate School of Medicine Osaka University, Osaka, Japan.
Purpose: We examined patient satisfaction with postoperative chest appearance after Nuss procedure and analyzed the factors for postoperative low satisfaction.
Methods: We retrospectively reviewed data of 133 patients who underwent the Nuss procedure from 2000 to 2016. Their medical records, X-rays, and computed tomography scans were evaluated.
Reply to Y. Usui et al.
J Clin Oncol
June 2020
Ana Lluch, PhD, Hospital Clínico Universitario de Valencia, Valencia; Biomedical Research Institute INCLIVA, University of Valencia, Valencia; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid; and GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Carlos H. Barrios, MD, Centro de Pesquisa Clínica Hospital São Lucas da PUCRS; and LACOG, Latin American Cooperative Oncology Group, Porto Alegre, Brazil, Laura Torrecillas, MD, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Ciudad de México, México; and Miguel Martín, MD, PhD, Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII; GEICAM, Spanish Breast Cancer Group; and Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.
J Diabetes Investig
July 2018
Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
We have reported that the HbA1c-lowering effects of liraglutide/basal insulin combination rely on remaining β-cell function and that the cut-off value of the C-peptide immunoreactivity index (CPI), a β-cell function-related index frequently used in Japanese clinical settings, is 1.103 for the achievement of HbA1c <7.0% at 54 weeks after initiating the liraglutide/basal insulin combination.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!